# Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives

Study · id `cardio:ct-nct02979197` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02979197](<https://clinicaltrials.gov/study/NCT02979197>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02979197

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT02979197. Randomized; triple masking; primary purpose treatment. Start 2016-11-03 (actual); primary completion 2017-07-21 (actual). Results posted on 2019-10-21.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT02979197, source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)
- Started: 2016-11-03 (actual) (ClinicalTrials.gov record NCT02979197, source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)
- Primary completion: 2017-07-21 (actual) (ClinicalTrials.gov record NCT02979197, source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)
- Completion: 2017-07-21 (actual) (ClinicalTrials.gov record NCT02979197, source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)
- Results first posted: 2019-10-21 (ClinicalTrials.gov record NCT02979197, source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02979197, source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02979197-2019-10-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives
- Condition: Hypertension
- Intervention (Drug): OE 10 mg amlodipine besylate tablet
- Intervention (Drug): OE 200 mg celecoxib capsule
- Intervention (Drug): Matched placebo for OE amlodipine besylate tablet
- Intervention (Drug): Matched placebo for OE celecoxib capsule
- Lead sponsor: Kitov Pharma Ltd
- Lead sponsor class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: c348d9044a857305d78c91bdc3276284f8d51bfac0f2d7da9762a26bd6d0b50f
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
